\n
\t\t\t\t\t\t| 英文名称 | \t\t\tinterferon alpha | \t\t
\t\t\t\t\t| 中文名称 | \t\t\t干扰素 α 抗体 | \t\t
\t\t\t\t\t| 别\xa0\xa0\xa0\xa0名 | \t\t\tinterferon alpha(1 + 2 + 3 + 4); INFAF; IFN-alpha1; IFL; IFN alpha; IFN; IFN-alpha-1; Interferon alpha 1; Interferon alpha 2; Interferon alpha 3; Interferon alpha 4; Interferon alpha 1; Interferon alpha 1/13 precursor; Interferon alpha 13; Interferon Alpha; Interferon Alpha; Interferon alpha D; Interferon alpha leukocyte; Interferon alpha-1/13; Interferon alpha-D; Interferon leukocyte; LeIF D; MGC138207; MGC138505; MGC138507; interferon alpha F precursor; interferon alpha-H-like; interferon alpha-G-like; interferon alpha-C-like.\xa0\xa0 | \t\t
\t\t\t\t\t| 研究领域 | \t\t\t\xa0 | \t\t
\t\t\t\t\t| 抗体来源 | \t\t\tRabbit | \t\t
\t\t\t\t\t| 克隆类型 | \t\t\tPolyclonal | \t\t
\t\t\t\t\t| 交叉反应 | \t\t\tCow,\xa0Sheep,\xa0 | \t\t
\t\t\t\t\t| 产品应用 | \t\t\tWB=1:500-2000\xa0ELISA=1:500-1000\xa0IHC-P=1:400-800\xa0IHC-F=1:400-800\xa0ICC=1:100-500\xa0IF=1:100-500\xa0(石蜡切片需做抗原修复)\xa0 \t\t\tnot yet tested in other applications. \t\t\toptimal dilutions/concentrations should be determined by the end user. | \t\t
\t\t\t\t\t| 分\xa0子\xa0量 | \t\t\t18kDa | \t\t
\t\t\t\t\t| 细胞定位 | \t\t\t分泌型蛋白\xa0 | \t\t
\t\t\t\t\t| 性\xa0\xa0\xa0\xa0状 | \t\t\tLyophilized or Liquid | \t\t
\t\t\t\t\t| 浓\xa0\xa0\xa0\xa0度 | \t\t\t1mg/ml | \t\t
\t\t\t\t\t| 免\xa0疫\xa0原 | \t\t\tKLH conjugated synthetic peptide derived from human interferon alpha:101-190/190\xa0 | \t\t
\t\t\t\t\t| 亚\xa0\xa0\xa0\xa0型 | \t\t\tIgG | \t\t
\t\t\t\t\t| 纯化方法 | \t\t\taffinity purified by Protein A | \t\t
\t\t\t\t\t| 储\xa0存\xa0液 | \t\t\t0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol. | \t\t
\t\t\t\t\t| 保存条件 | \t\t\tStore at -20 °C for one year. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year when kept at -20°C. When reconstituted in sterile pH 7.4 0.01M PBS or diluent of antibody the antibody is stable for at least two weeks at 2-4 °C. | \t\t
\t\t\t\t
\t
\t
\t\t\t\t\t| 英文名称 | \t\t\tinterferon alpha | \t\t
\t\t\t\t\t| 中文名称 | \t\t\t干扰素 α 抗体 | \t\t
\t\t\t\t\t| 别\xa0\xa0\xa0\xa0名 | \t\t\tinterferon alpha(1 + 2 + 3 + 4); INFAF; IFN-alpha1; IFL; IFN alpha; IFN; IFN-alpha-1; Interferon alpha 1; Interferon alpha 2; Interferon alpha 3; Interferon alpha 4; Interferon alpha 1; Interferon alpha 1/13 precursor; Interferon alpha 13; Interferon Alpha; Interferon Alpha; Interferon alpha D; Interferon alpha leukocyte; Interferon alpha-1/13; Interferon alpha-D; Interferon leukocyte; LeIF D; MGC138207; MGC138505; MGC138507; interferon alpha F precursor; interferon alpha-H-like; interferon alpha-G-like; interferon alpha-C-like.\xa0\xa0 | \t\t
\t\t\t\t\t| 研究领域 | \t\t\t\xa0 | \t\t
\t\t\t\t\t| 抗体来源 | \t\t\tRabbit | \t\t
\t\t\t\t\t| 克隆类型 | \t\t\tPolyclonal | \t\t
\t\t\t\t\t| 交叉反应 | \t\t\tCow,\xa0Sheep,\xa0 | \t\t
\t\t\t\t\t| 产品应用 | \t\t\tWB=1:500-2000\xa0ELISA=1:500-1000\xa0IHC-P=1:400-800\xa0IHC-F=1:400-800\xa0ICC=1:100-500\xa0IF=1:100-500\xa0(石蜡切片需做抗原修复)\xa0 \t\t\tnot yet tested in other applications. \t\t\toptimal dilutions/concentrations should be determined by the end user. | \t\t
\t\t\t\t\t| 分\xa0子\xa0量 | \t\t\t18kDa | \t\t
\t\t\t\t\t| 细胞定位 | \t\t\t分泌型蛋白\xa0 | \t\t
\t\t\t\t\t| 性\xa0\xa0\xa0\xa0状 | \t\t\tLyophilized or Liquid | \t\t
\t\t\t\t\t| 浓\xa0\xa0\xa0\xa0度 | \t\t\t1mg/ml | \t\t
\t\t\t\t\t| 免\xa0疫\xa0原 | \t\t\tKLH conjugated synthetic peptide derived from human interferon alpha:101-190/190\xa0 | \t\t
\t\t\t\t\t| 亚\xa0\xa0\xa0\xa0型 | \t\t\tIgG | \t\t
\t\t\t\t\t| 纯化方法 | \t\t\taffinity purified by Protein A | \t\t
\t\t\t\t\t| 储\xa0存\xa0液 | \t\t\t0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol. | \t\t
\t\t\t\t\t| 保存条件 | \t\t\tStore at -20 °C for one year. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year when kept at -20°C. When reconstituted in sterile pH 7.4 0.01M PBS or diluent of antibody the antibody is stable for at least two weeks at 2-4 °C. | \t\t
\t\t\t\t
\t\t\t
\t\t\t| 英文名称 | \t\t\tinterferon alpha | \t\t
\t\t\t
英文名称 | 英文名称英文名称英文名称英文名称英文名称英文名称英文名称英文名称\t\t\t
interferon alpha | interferon alphainterferon alphainterferon alphainterferon alphainterferon alphainterferon alphainterferon alphainterferon alpha\t\t\t\t
\t\t\t| 中文名称 | \t\t\t干扰素 α 抗体 | \t\t
\t\t\t
中文名称 | 中文名称中文名称中文名称中文名称中文名称中文名称中文名称中文名称\t\t\t
干扰素 α 抗体 | 干扰素 α 抗体干扰素 α 抗体干扰素 α 抗体干扰素 α 抗体干扰素 α 抗体干扰素 α 抗体干扰素 α 抗体干扰素 α 抗体\t\t\t\t
\t\t\t| 别\xa0\xa0\xa0\xa0名 | \t\t\tinterferon alpha(1 + 2 + 3 + 4); INFAF; IFN-alpha1; IFL; IFN alpha; IFN; IFN-alpha-1; Interferon alpha 1; Interferon alpha 2; Interferon alpha 3; Interferon alpha 4; Interferon alpha 1; Interferon alpha 1/13 precursor; Interferon alpha 13; Interferon Alpha; Interferon Alpha; Interferon alpha D; Interferon alpha leukocyte; Interferon alpha-1/13; Interferon alpha-D; Interferon leukocyte; LeIF D; MGC138207; MGC138505; MGC138507; interferon alpha F precursor; interferon alpha-H-like; interferon alpha-G-like; interferon alpha-C-like.\xa0\xa0 | \t\t
\t\t\t
别\xa0\xa0\xa0\xa0名 | 别\xa0\xa0\xa0\xa0名别\xa0\xa0\xa0\xa0名别\xa0\xa0\xa0\xa0名别\xa0\xa0\xa0\xa0名别\xa0\xa0\xa0\xa0名别\xa0\xa0\xa0\xa0名别\xa0\xa0\xa0\xa0名别\xa0\xa0\xa0\xa0名\t\t\t
interferon alpha(1 + 2 + 3 + 4); INFAF; IFN-alpha1; IFL; IFN alpha; IFN; IFN-alpha-1; Interferon alpha 1; Interferon alpha 2; Interferon alpha 3; Interferon alpha 4; Interferon alpha 1; Interferon alpha 1/13 precursor; Interferon alpha 13; Interferon Alpha; Interferon Alpha; Interferon alpha D; Interferon alpha leukocyte; Interferon alpha-1/13; Interferon alpha-D; Interferon leukocyte; LeIF D; MGC138207; MGC138505; MGC138507; interferon alpha F precursor; interferon alpha-H-like; interferon alpha-G-like; interferon alpha-C-like.\xa0\xa0 | interferon alpha(1 + 2 + 3 + 4); INFAF; IFN-alpha1; IFL; IFN alpha; IFN; IFN-alpha-1; Interferon alpha 1; Interferon alpha 2; Interferon alpha 3; Interferon alpha 4; Interferon alpha 1; Interferon alpha 1/13 precursor; Interferon alpha 13; Interferon Alpha; Interferon Alpha; Interferon alpha D; Interferon alpha leukocyte; Interferon alpha-1/13; Interferon alpha-D; Interferon leukocyte; LeIF D; MGC138207; MGC138505; MGC138507; interferon alpha F precursor; interferon alpha-H-like; interferon alpha-G-like; interferon alpha-C-like.\xa0\xa0interferon alpha(1 + 2 + 3 + 4); INFAF; IFN-alpha1; IFL; IFN alpha; IFN; IFN-alpha-1; Interferon alpha 1; Interferon alpha 2; Interferon alpha 3; Interferon alpha 4; Interferon alpha 1; Interferon alpha 1/13 precursor; Interferon alpha 13; Interferon Alpha; Interferon Alpha; Interferon alpha D; Interferon alpha leukocyte; Interferon alpha-1/13; Interferon alpha-D; Interferon leukocyte; LeIF D; MGC138207; MGC138505; MGC138507; interferon alpha F precursor; interferon alpha-H-like; interferon alpha-G-like; interferon alpha-C-like.\xa0\xa0interferon alpha(1 + 2 + 3 + 4); INFAF; IFN-alpha1; IFL; IFN alpha; IFN; IFN-alpha-1; Interferon alpha 1; Interferon alpha 2; Interferon alpha 3; Interferon alpha 4; Interferon alpha 1; Interferon alpha 1/13 precursor; Interferon alpha 13; Interferon Alpha; Interferon Alpha; Interferon alpha D; Interferon alpha leukocyte; Interferon alpha-1/13; Interferon alpha-D; Interferon leukocyte; LeIF D; MGC138207; MGC138505; MGC138507; interferon alpha F precursor; interferon alpha-H-like; interferon alpha-G-like; interferon alpha-C-like.\xa0\xa0interferon alpha(1 + 2 + 3 + 4); INFAF; IFN-alpha1; IFL; IFN alpha; IFN; IFN-alpha-1; Interferon alpha 1; Interferon alpha 2; Interferon alpha 3; Interferon alpha 4; Interferon alpha 1; Interferon alpha 1/13 precursor; Interferon alpha 13; Interferon Alpha; Interferon Alpha; Interferon alpha D; Interferon alpha leukocyte; Interferon alpha-1/13; Interferon alpha-D; Interferon leukocyte; LeIF D; MGC138207; MGC138505; MGC138507; interferon alpha F precursor; interferon alpha-H-like; interferon alpha-G-like; interferon alpha-C-like.\xa0\xa0interferon alpha(1 + 2 + 3 + 4); INFAF; IFN-alpha1; IFL; IFN alpha; IFN; IFN-alpha-1; Interferon alpha 1; Interferon alpha 2; Interferon alpha 3; Interferon alpha 4; Interferon alpha 1; Interferon alpha 1/13 precursor; Interferon alpha 13; Interferon Alpha; Interferon Alpha; Interferon alpha D; Interferon alpha leukocyte; Interferon alpha-1/13; Interferon alpha-D; Interferon leukocyte; LeIF D; MGC138207; MGC138505; MGC138507; interferon alpha F precursor; interferon alpha-H-like; interferon alpha-G-like; interferon alpha-C-like.\xa0\xa0interferon alpha(1 + 2 + 3 + 4); INFAF; IFN-alpha1; IFL; IFN alpha; IFN; IFN-alpha-1; Interferon alpha 1; Interferon alpha 2; Interferon alpha 3; Interferon alpha 4; Interferon alpha 1; Interferon alpha 1/13 precursor; Interferon alpha 13; Interferon Alpha; Interferon Alpha; Interferon alpha D; Interferon alpha leukocyte; Interferon alpha-1/13; Interferon alpha-D; Interferon leukocyte; LeIF D; MGC138207; MGC138505; MGC138507; interferon alpha F precursor; interferon alpha-H-like; interferon alpha-G-like; interferon alpha-C-like.\xa0\xa0interferon alpha(1 + 2 + 3 + 4); INFAF; IFN-alpha1; IFL; IFN alpha; IFN; IFN-alpha-1; Interferon alpha 1; Interferon alpha 2; Interferon alpha 3; Interferon alpha 4; Interferon alpha 1; Interferon alpha 1/13 precursor; Interferon alpha 13; Interferon Alpha; Interferon Alpha; Interferon alpha D; Interferon alpha leukocyte; Interferon alpha-1/13; Interferon alpha-D; Interferon leukocyte; LeIF D; MGC138207; MGC138505; MGC138507; interferon alpha F precursor; interferon alpha-H-like; interferon alpha-G-like; interferon alpha-C-like.\xa0\xa0interferon alpha(1 + 2 + 3 + 4); INFAF; IFN-alpha1; IFL; IFN alpha; IFN; IFN-alpha-1; Interferon alpha 1; Interferon alpha 2; Interferon alpha 3; Interferon alpha 4; Interferon alpha 1; Interferon alpha 1/13 precursor; Interferon alpha 13; Interferon Alpha; Interferon Alpha; Interferon alpha D; Interferon alpha leukocyte; Interferon alpha-1/13; Interferon alpha-D; Interferon leukocyte; LeIF D; MGC138207; MGC138505; MGC138507; interferon alpha F precursor; interferon alpha-H-like; interferon alpha-G-like; interferon alpha-C-like.\xa0\xa0\t\t\t\t
\t\t\t| 研究领域 | \t\t\t\xa0 | \t\t
\t\t\t
研究领域 | 研究领域研究领域研究领域研究领域研究领域研究领域研究领域研究领域\t\t\t
\xa0 | \xa0\t\t\t\t
\t\t\t| 抗体来源 | \t\t\tRabbit | \t\t
\t\t\t
抗体来源 | 抗体来源抗体来源抗体来源抗体来源抗体来源抗体来源抗体来源抗体来源\t\t\t
Rabbit | RabbitRabbitRabbitRabbitRabbitRabbitRabbitRabbit\t\t\t\t
\t\t\t| 克隆类型 | \t\t\tPolyclonal | \t\t
\t\t\t
克隆类型 | 克隆类型克隆类型克隆类型克隆类型克隆类型克隆类型克隆类型克隆类型\t\t\t
Polyclonal | PolyclonalPolyclonalPolyclonalPolyclonalPolyclonalPolyclonalPolyclonalPolyclonal\t\t\t\t
\t\t\t| 交叉反应 | \t\t\tCow,\xa0Sheep,\xa0 | \t\t
\t\t\t
交叉反应 | 交叉反应交叉反应交叉反应交叉反应交叉反应交叉反应交叉反应交叉反应\t\t\t
Cow,\xa0Sheep,\xa0 | Cow,\xa0Sheep,\xa0Cow,\xa0Sheep,\xa0Cow,\xa0Sheep,\xa0Cow,\xa0Sheep,\xa0Cow,\xa0Sheep,\xa0Cow,\xa0Sheep,\xa0Cow,\xa0Sheep,\xa0Cow,\xa0Sheep,\xa0\t\t\t\t
\t\t\t| 产品应用 | \t\t\tWB=1:500-2000\xa0ELISA=1:500-1000\xa0IHC-P=1:400-800\xa0IHC-F=1:400-800\xa0ICC=1:100-500\xa0IF=1:100-500\xa0(石蜡切片需做抗原修复)\xa0 \t\t\tnot yet tested in other applications. \t\t\toptimal dilutions/concentrations should be determined by the end user. | \t\t
\t\t\t
产品应用 | 产品应用产品应用产品应用产品应用产品应用产品应用产品应用产品应用\t\t\t
WB=1:500-2000\xa0ELISA=1:500-1000\xa0IHC-P=1:400-800\xa0IHC-F=1:400-800\xa0ICC=1:100-500\xa0IF=1:100-500\xa0(石蜡切片需做抗原修复)\xa0 \t\t\tnot yet tested in other applications. \t\t\toptimal dilutions/concentrations should be determined by the end user. | WB=1:500-2000\xa0ELISA=1:500-1000\xa0IHC-P=1:400-800\xa0IHC-F=1:400-800\xa0ICC=1:100-500\xa0IF=1:100-500\xa0(石蜡切片需做抗原修复)\xa0
\t\t\tnot yet tested in other applications.
\t\t\toptimal dilutions/concentrations should be determined by the end user.WB=1:500-2000\xa0ELISA=1:500-1000\xa0IHC-P=1:400-800\xa0IHC-F=1:400-800\xa0ICC=1:100-500\xa0IF=1:100-500\xa0(石蜡切片需做抗原修复)\xa0
\t\t\tnot yet tested in other applications.
\t\t\toptimal dilutions/concentrations should be determined by the end user.WB=1:500-2000\xa0ELISA=1:500-1000\xa0IHC-P=1:400-800\xa0IHC-F=1:400-800\xa0ICC=1:100-500\xa0IF=1:100-500\xa0(石蜡切片需做抗原修复)\xa0
\t\t\tnot yet tested in other applications.
\t\t\toptimal dilutions/concentrations should be determined by the end user.WB=1:500-2000\xa0ELISA=1:500-1000\xa0IHC-P=1:400-800\xa0IHC-F=1:400-800\xa0ICC=1:100-500\xa0IF=1:100-500\xa0(石蜡切片需做抗原修复)\xa0
\t\t\tnot yet tested in other applications.
\t\t\toptimal dilutions/concentrations should be determined by the end user.WB=1:500-2000\xa0ELISA=1:500-1000\xa0IHC-P=1:400-800\xa0IHC-F=1:400-800\xa0ICC=1:100-500\xa0IF=1:100-500\xa0(石蜡切片需做抗原修复)\xa0
\t\t\tnot yet tested in other applications.
\t\t\toptimal dilutions/concentrations should be determined by the end user.WB=1:500-2000\xa0ELISA=1:500-1000\xa0IHC-P=1:400-800\xa0IHC-F=1:400-800\xa0ICC=1:100-500\xa0IF=1:100-500\xa0(石蜡切片需做抗原修复)\xa0
\t\t\tnot yet tested in other applications.
\t\t\toptimal dilutions/concentrations should be determined by the end user.WB=1:500-2000\xa0ELISA=1:500-1000\xa0IHC-P=1:400-800\xa0IHC-F=1:400-800\xa0ICC=1:100-500\xa0IF=1:100-500\xa0(石蜡切片需做抗原修复)\xa0
\t\t\tnot yet tested in other applications.
\t\t\toptimal dilutions/concentrations should be determined by the end user.WB=1:500-2000\xa0ELISA=1:500-1000\xa0IHC-P=1:400-800\xa0IHC-F=1:400-800\xa0ICC=1:100-500\xa0IF=1:100-500\xa0(石蜡切片需做抗原修复)\xa0
\t\t\tnot yet tested in other applications.
\t\t\toptimal dilutions/concentrations should be determined by the end user.\t\t\t\t
\t\t\t| 分\xa0子\xa0量 | \t\t\t18kDa | \t\t
\t\t\t
分\xa0子\xa0量 | 分\xa0子\xa0量分\xa0子\xa0量分\xa0子\xa0量分\xa0子\xa0量分\xa0子\xa0量分\xa0子\xa0量分\xa0子\xa0量分\xa0子\xa0量\t\t\t
18kDa | 18kDa18kDa18kDa18kDa18kDa18kDa18kDa18kDa\t\t\t\t
\t\t\t| 细胞定位 | \t\t\t分泌型蛋白\xa0 | \t\t
\t\t\t
细胞定位 | 细胞定位细胞定位细胞定位细胞定位细胞定位细胞定位细胞定位细胞定位\t\t\t
分泌型蛋白\xa0 | 分泌型蛋白\xa0分泌型蛋白\xa0分泌型蛋白\xa0分泌型蛋白\xa0分泌型蛋白\xa0分泌型蛋白\xa0分泌型蛋白\xa0分泌型蛋白\xa0\t\t\t\t
\t\t\t| 性\xa0\xa0\xa0\xa0状 | \t\t\tLyophilized or Liquid | \t\t
\t\t\t
性\xa0\xa0\xa0\xa0状 | 性\xa0\xa0\xa0\xa0状性\xa0\xa0\xa0\xa0状性\xa0\xa0\xa0\xa0状性\xa0\xa0\xa0\xa0状性\xa0\xa0\xa0\xa0状性\xa0\xa0\xa0\xa0状性\xa0\xa0\xa0\xa0状性\xa0\xa0\xa0\xa0状\t\t\t
Lyophilized or Liquid | Lyophilized or LiquidLyophilized or LiquidLyophilized or LiquidLyophilized or LiquidLyophilized or LiquidLyophilized or LiquidLyophilized or LiquidLyophilized or Liquid\t\t\t\t
\t\t\t| 浓\xa0\xa0\xa0\xa0度 | \t\t\t1mg/ml | \t\t
\t\t\t
浓\xa0\xa0\xa0\xa0度 | 浓\xa0\xa0\xa0\xa0度浓\xa0\xa0\xa0\xa0度浓\xa0\xa0\xa0\xa0度浓\xa0\xa0\xa0\xa0度浓\xa0\xa0\xa0\xa0度浓\xa0\xa0\xa0\xa0度浓\xa0\xa0\xa0\xa0度浓\xa0\xa0\xa0\xa0度\t\t\t
1mg/ml | 1mg/ml1mg/ml1mg/ml1mg/ml1mg/ml1mg/ml1mg/ml1mg/ml\t\t\t\t
\t\t\t| 免\xa0疫\xa0原 | \t\t\tKLH conjugated synthetic peptide derived from human interferon alpha:101-190/190\xa0 | \t\t
\t\t\t
免\xa0疫\xa0原 | 免\xa0疫\xa0原免\xa0疫\xa0原免\xa0疫\xa0原免\xa0疫\xa0原免\xa0疫\xa0原免\xa0疫\xa0原免\xa0疫\xa0原免\xa0疫\xa0原\t\t\t
KLH conjugated synthetic peptide derived from human interferon alpha:101-190/190\xa0 | KLH conjugated synthetic peptide derived from human interferon alpha:101-190/190\xa0KLH conjugated synthetic peptide derived from human interferon alpha:101-190/190\xa0KLH conjugated synthetic peptide derived from human interferon alpha:101-190/190\xa0KLH conjugated synthetic peptide derived from human interferon alpha:101-190/190\xa0KLH conjugated synthetic peptide derived from human interferon alpha:101-190/190\xa0KLH conjugated synthetic peptide derived from human interferon alpha:101-190/190\xa0KLH conjugated synthetic peptide derived from human interferon alpha:101-190/190\xa0KLH conjugated synthetic peptide derived from human interferon alpha:101-190/190\xa0\t\t\t\t
\t\t\t| 亚\xa0\xa0\xa0\xa0型 | \t\t\tIgG | \t\t
\t\t\t
亚\xa0\xa0\xa0\xa0型 | 亚\xa0\xa0\xa0\xa0型亚\xa0\xa0\xa0\xa0型亚\xa0\xa0\xa0\xa0型亚\xa0\xa0\xa0\xa0型亚\xa0\xa0\xa0\xa0型亚\xa0\xa0\xa0\xa0型亚\xa0\xa0\xa0\xa0型亚\xa0\xa0\xa0\xa0型\t\t\t
IgG | IgGIgGIgGIgGIgGIgGIgGIgG\t\t\t\t
\t\t\t| 纯化方法 | \t\t\taffinity purified by Protein A | \t\t
\t\t\t
纯化方法 | 纯化方法纯化方法纯化方法纯化方法纯化方法纯化方法纯化方法纯化方法\t\t\t
affinity purified by Protein A | affinity purified by Protein Aaffinity purified by Protein Aaffinity purified by Protein Aaffinity purified by Protein Aaffinity purified by Protein Aaffinity purified by Protein Aaffinity purified by Protein Aaffinity purified by Protein A\t\t\t\t
\t\t\t| 储\xa0存\xa0液 | \t\t\t0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol. | \t\t
\t\t\t
储\xa0存\xa0液 | 储\xa0存\xa0液储\xa0存\xa0液储\xa0存\xa0液储\xa0存\xa0液储\xa0存\xa0液储\xa0存\xa0液储\xa0存\xa0液储\xa0存\xa0液\t\t\t
0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol. | 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.\t\t\t\t
\t\t\t| 保存条件 | \t\t\tStore at -20 °C for one year. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year when kept at -20°C. When reconstituted in sterile pH 7.4 0.01M PBS or diluent of antibody the antibody is stable for at least two weeks at 2-4 °C. | \t\t
\t\t\t
保存条件 | 保存条件保存条件保存条件保存条件保存条件保存条件保存条件保存条件\t\t\t
Store at -20 °C for one year. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year when kept at -20°C. When reconstituted in sterile pH 7.4 0.01M PBS or diluent of antibody the antibody is stable for at least two weeks at 2-4 °C. | Store at -20 °C for one year. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year when kept at -20°C. When reconstituted in sterile pH 7.4 0.01M PBS or diluent of antibody the antibody is stable for at least two weeks at 2-4 °C.Store at -20 °C for one year. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year when kept at -20°C. When reconstituted in sterile pH 7.4 0.01M PBS or diluent of antibody the antibody is stable for at least two weeks at 2-4 °C.Store at -20 °C for one year. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year when kept at -20°C. When reconstituted in sterile pH 7.4 0.01M PBS or diluent of antibody the antibody is stable for at least two weeks at 2-4 °C.Store at -20 °C for one year. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year when kept at -20°C. When reconstituted in sterile pH 7.4 0.01M PBS or diluent of antibody the antibody is stable for at least two weeks at 2-4 °C.Store at -20 °C for one year. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year when kept at -20°C. When reconstituted in sterile pH 7.4 0.01M PBS or diluent of antibody the antibody is stable for at least two weeks at 2-4 °C.Store at -20 °C for one year. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year when kept at -20°C. When reconstituted in sterile pH 7.4 0.01M PBS or diluent of antibody the antibody is stable for at least two weeks at 2-4 °C.Store at -20 °C for one year. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year when kept at -20°C. When reconstituted in sterile pH 7.4 0.01M PBS or diluent of antibody the antibody is stable for at least two weeks at 2-4 °C.Store at -20 °C for one year. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year when kept at -20°C. When reconstituted in sterile pH 7.4 0.01M PBS or diluent of antibody the antibody is stable for at least two weeks at 2-4 °C.\t\t\t\t
\t\t
\t\t\t